Gelonghui, August 4?Some investors asked Shuanglu Pharmaceutical (002038.SZ), "is it possible for compound coenzymes to be included in health insurance in the future?" Has the company made any efforts in this regard? "
Shuanglu Pharmaceutical replied that the compound coenzyme had not been included in the national health insurance before, but had been included in the provincial health insurance in more than 20 provinces and cities. This variety is safe and effective, and the company will strive to be included in the health insurance catalogue at the right time while continuing to increase the promotion of its products.